Export 1889 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Barrias, C. C., Ribeiro, C. C., Martins, M. C. L., Barbosa, M. A., et al. (2006). Calcium phosphate microspheres for localised delivery of a therapeutic enzyme. Key Engineering Materials (Vol. 309-311 II, pp. 903 - 906).
Silva, K., Correia, R., Lima, M., Magalhães, A., & de Sousa, L. (2011). Can dogs prime autistic children for therapy? evidence from a single case study. Journal of Alternative and Complementary Medicine, 17(7), 655 - 659.
Lima, M., Silva, K., Magalhães, A., Amaral, I., et al. (2012). Can you Know me Better? An Exploratory Study Combining Behavioural and Physiological Measurements for an Objective Assessment of Sensory Responsiveness in a Child with Profound Intellectual and Multiple Disabilities. Journal of Applied Research in Intellectual Disabilities, 25(6), 522 - 530.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Cardoso, L., Yisaschar-Mekuzas, Y., Rodrigues, F. T., Costa, Á., et al. (2010). Canine babesiosis in northern Portugal and molecular characterization of vector-borne co-infections. Parasites and Vectors, 3(1).
Miró, G., Cardoso, L., Pennisi, M. G., Oliva, G., & Baneth, G. (2008). Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part two. Trends in Parasitology, 24(8), 371 - 377.
Pereira, M., Valério-Bolas, A., Santos-Mateus, D., Alexandre-Pires, G., et al. (2017). Canine neutrophils activate effector mechanisms in response to Leishmania infantum. Veterinary Parasitology, 248, 10 - 20.
Pimenta, P., Cardoso, L., Pereira, M. J., Maltez, L., et al. (2013). Canine ocular thelaziosis caused by Thelazia callipaeda in Portugal. Veterinary Ophthalmology, 16(4), 312 - 315.
Moreira-Rodrigues, M., Henriques-Coelho, T., Moura, C., Vasques-Nóvoa, F., et al. (2010). Cardiac dysfunction in HgCl2-induced nephrotic syndrome. Experimental Biology and Medicine, 235(3), 392 - 400.
Moreira-Rodrigues, M., Henriques-Coelho, T., Moura, C., Vasques-Nóvoa, F., et al. (2010). Cardiac dysfunction in HgCl2-induced nephrotic syndrome. Experimental Biology and Medicine, 235(3), 392 - 400.
Nascimento, H., Costa, E., Rocha-Pereira, P., Rego, C., et al. (2012). Cardiovascular risk factors in Portuguese obese children and adolescents: Impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochemistry Journal, 6, 43 - 50.
Félix, L., Oliveira, M. M., Videira, R., Maciel, E., et al. (2017). Carvedilol exacerbate gentamicin-induced kidney mitochondrial alterations in adult rat. Experimental and Toxicologic Pathology, 69(2), 83 - 92.
Macedo, B., Magalhães, J., Batista, A. R., & Saraiva, M. J. (2010). Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacological Research, 62(6), 514 - 522.
Macedo, B., Magalhães, J., Batista, A. R., & Saraiva, M. J. (2010). Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacological Research, 62(6), 514 - 522.
Faísca, P., Morales-Hojas, R., Alves, M., Gomes, J., et al. (2010). A case of canine ocular onchocercosis in Portugal. Veterinary Ophthalmology, 13(2), 117 - 121.
Faísca, P., Morales-Hojas, R., Alves, M., Gomes, J., et al. (2010). A case of canine ocular onchocercosis in Portugal. Veterinary Ophthalmology, 13(2), 117 - 121.
Almeida, H., Matos, L., & Neves, D. (2007). Caspase-3 and Bcl-2 expression in aging in adrenal zona reticularis after dexamethasone administration. Annals of the New York Academy of Sciences (Vol. 1119, pp. 190 - 195).
Correia, A. P., Pinto, J. P., Dias, V., Mascarenhas, C., et al. (2009). CAT53 and HFE alleles in Alzheimer's disease: A putative protective role of the C282Y HFE mutation. Neuroscience Letters, 457(3), 129 - 132.
Vieira-Coelho, M. A., Serrão, M. P., Afonso, J., Pinto, C. E., & Moura, E. (2009). Catecholamine synthesis and metabolism in the central nervous system of mice lacking α 2-adrenoceptor subtypes: RESEARCH PAPER. British Journal of Pharmacology, 158(3), 726 - 737.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc